Literature DB >> 1521036

Effect of nicotine on mRNA levels encoding opioid peptides, vasopressin and alpha 3 nicotinic receptor subunit in the rat.

V Höllt1, G Horn.   

Abstract

The effect of acute and chronic nicotine treatment of rats on the mRNA levels coding for the three opioid peptide precursors, for provasopressin and for the alpha 3 subunit of nicotinic receptors in brain, pituitary and/or adrenal medulla of rats was investigated. Nicotine was found to increase the levels of proenkephalin mRNA in the adrenal medulla, but did not affect the levels of PENK mRNA in striatum, hypothalamus and hippocampus. The mRNA levels of prodynorphin were increased together with that of provasopressin in the hypothalamus after nicotine, whereas the prodynorphin mRNA levels in the hippocampus and the striatum remained unchanged. Nicotine treatment resulted in an increase in the pro-opiomelanocortin mRNA levels in the anterior pituitary and in a decrease in the intermediate pituitary, but did not change the levels of pro-opiomelanocortin mRNA in the hypothalamus. The levels of mRNA coding for the alpha 3 subunit of nicotinic receptors in the hypothalamus and the adrenal medulla remained unchanged. The increase in the prodynorphin and provasopressin mRNA levels in the hypothalamus was most pronounced 1 day after s.c. application of two doses of 0.4 mg/kg nicotine (about 100% above control). A smaller increase in mRNA concentrations (about 30%) was found after tonic infusion of the drug for 4 days (4 mg/kg per day), whereas no change was observed after tonic infusion of nicotine for 7 and 14 days indicating the development of complete tolerance.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521036     DOI: 10.1007/bf00184655

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  24 in total

Review 1.  Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors.

Authors:  E S Deneris; J Connolly; S W Rogers; R Duvoisin
Journal:  Trends Pharmacol Sci       Date:  1991-01       Impact factor: 14.819

Review 2.  Regulation of brain nicotinic cholinergic recognition sites and prolactin release by nicotine.

Authors:  K J Kellar; B A Giblin; M D Lumpkin
Journal:  Prog Brain Res       Date:  1989       Impact factor: 2.453

3.  Differential polyadenylation of the mutant vasopressin mRNA during development of Brattleboro rats.

Authors:  S Fehr; H Schmale; D Richter
Journal:  Biochem Biophys Res Commun       Date:  1989-01-31       Impact factor: 3.575

4.  Dynorphin and vasopressin: common localization in magnocellular neurons.

Authors:  S J Watson; H Akil; W Fischli; A Goldstein; E Zimmerman; G Nilaver; T B van wimersma Griedanus
Journal:  Science       Date:  1982-04-02       Impact factor: 47.728

5.  Neuroendocrine reactivity to nicotine in smokers.

Authors:  O F Pomerleau; J B Fertig; L E Seyler; J Jaffe
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  The action of nicotine on the pituitary-adrenal cortical axis.

Authors:  G R Cam; J R Bassett; K D Cairncross
Journal:  Arch Int Pharmacodyn Ther       Date:  1979-01

7.  Stimulation of nigrostriatal dopamine neurones by nicotine.

Authors:  W Lichtensteiger; F Hefti; D Felix; T Huwyler; E Melamed; M Schlumpf
Journal:  Neuropharmacology       Date:  1982-10       Impact factor: 5.250

8.  The effect of systemically applied cholinergic drugs on the striatal release of dopamine and its metabolites, as determined by automated brain dialysis in conscious rats.

Authors:  G Damsma; B H Westerink; J B de Vries; A S Horn
Journal:  Neurosci Lett       Date:  1988-07-08       Impact factor: 3.046

9.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

10.  The release of vasopressin by nicotine: further studies on its site of action.

Authors:  E Castro de Souza; M Rocha E Silva
Journal:  J Physiol       Date:  1977-02       Impact factor: 5.182

View more
  6 in total

Review 1.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 2.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

3.  Nicotine-induced gene expression of proenkephalin in bovine chromaffin cells.

Authors:  X Wang; B Bacher; V Höllt
Journal:  Clin Investig       Date:  1994-11

Review 4.  Smoking and the pathogenesis of gastroduodenal ulcer--recent mechanistic update.

Authors:  Pallab Maity; Kaushik Biswas; Somenath Roy; Ranajit K Banerjee; Uday Bandyopadhyay
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

Review 5.  Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response.

Authors:  Burcu Balkan; Sakire Pogun
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 6.  The role of enkephalinergic systems in substance use disorders.

Authors:  Lauren G Rysztak; Emily M Jutkiewicz
Journal:  Front Syst Neurosci       Date:  2022-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.